Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4557261
Max Phase: Preclinical
Molecular Formula: C15H11Cl2NO2S
Molecular Weight: 340.23
Molecule Type: Unknown
Associated Items:
ID: ALA4557261
Max Phase: Preclinical
Molecular Formula: C15H11Cl2NO2S
Molecular Weight: 340.23
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)CCN1c2ccc(Cl)cc2Sc2cc(Cl)ccc21
Standard InChI: InChI=1S/C15H11Cl2NO2S/c16-9-1-3-11-13(7-9)21-14-8-10(17)2-4-12(14)18(11)6-5-15(19)20/h1-4,7-8H,5-6H2,(H,19,20)
Standard InChI Key: LDIVBPQKXNEANT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 340.23 | Molecular Weight (Monoisotopic): 338.9888 | AlogP: 5.07 | #Rotatable Bonds: 3 |
Polar Surface Area: 40.54 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.85 | CX Basic pKa: | CX LogP: 4.78 | CX LogD: 1.54 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.85 | Np Likeness Score: -0.94 |
1. (2018) Modulation of K2P channels, |
2. (2016) Modulation of k2p channels, |
Source(1):